Noninvasive respiratory support following extubation in critically ill adults with obesity: a systematic review and network meta-analysisResearch in context

Summary: Background: Patients with obesity are at high-risk of extubation failure. Discrepancies were found in the results of recent randomized controlled trials (RCTs) regarding the roles of noninvasive ventilation (NIV), high flow nasal cannula (HFNC) and conventional oxygen therapy (COT) to prev...

Full description

Saved in:
Bibliographic Details
Main Authors: Joris Pensier, Arthur Naudet-Lasserre, Clément Monet, Mathieu Capdevila, Yassir Aarab, Inès Lakbar, Gérald Chanques, Nicolas Molinari, Audrey De Jong, Samir Jaber
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537024005819
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591801374998528
author Joris Pensier
Arthur Naudet-Lasserre
Clément Monet
Mathieu Capdevila
Yassir Aarab
Inès Lakbar
Gérald Chanques
Nicolas Molinari
Audrey De Jong
Samir Jaber
author_facet Joris Pensier
Arthur Naudet-Lasserre
Clément Monet
Mathieu Capdevila
Yassir Aarab
Inès Lakbar
Gérald Chanques
Nicolas Molinari
Audrey De Jong
Samir Jaber
author_sort Joris Pensier
collection DOAJ
description Summary: Background: Patients with obesity are at high-risk of extubation failure. Discrepancies were found in the results of recent randomized controlled trials (RCTs) regarding the roles of noninvasive ventilation (NIV), high flow nasal cannula (HFNC) and conventional oxygen therapy (COT) to prevent extubation failure in critically ill patients with obesity. Methods: In this systematic review and network meta-analysis, we searched MEDLINE, Cochrane Center Register of Controlled Trials and Web of Science from 1 January 1998 to 1 July 2024 for RCTs evaluating noninvasive respiratory support therapies (NIV, HFNC, COT, NIV + HFNC) after extubation in critically ill adults with obesity. Primary outcome was reintubation at day 7. Secondary outcome was 28-day mortality. We generated pooled risk ratios (RR) and numbers needed to treat (NNT). We rated risk of bias using the Cochrane risk-of-bias 2.0 tool. The study was registered with PROSPERO (CRD 42022308995). Findings: In seven RCTs including 1933 patients, NIV + HFNC (RR 0.36 [95% confidence interval (CI) 0.16–0.82], NNT = 10 [95% CI 7–33]) and NIV (RR 0.45 [95% CI 0.23–0.88], NNT = 11 [95% CI 8–50]) but not HFNC (RR 0.79 [95% CI 0.40–1.59]) reduced reintubation at day 7, compared to COT. Compared to HFNC, NIV + HFNC (RR 0.46 [95% CI 0.23–0.90], NNT = 14 [95% CI 10–77]) but not NIV (RR 0.57 [95% CI 0.32–1.02]) reduced reintubation at day 7. Compared to HFNC, both NIV (RR 0.31 [95% CI 0.13–0.74], NNT = 15 [95% CI 12–40]) and NIV + HFNC (RR 0.30 [95% CI 0.10–0.89], NNT = 15 [95% CI 11–90]) reduced 28-day mortality. Interpretation: The results suggest that compared to COT and HFNC, NIV alone or with HFNC reduces reintubation in critically ill patients with obesity after extubation. Compared to HFNC, NIV alone or with HFNC reduces mortality. The number needed to treat with NIV or NIV + HFNC to avoid one death was 15. These findings support the application of NIV to mitigate extubation failure in critically ill adults with obesity. Funding: None.
format Article
id doaj-art-d9f9a466f35646a7abc572c1bd239f2d
institution Kabale University
issn 2589-5370
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj-art-d9f9a466f35646a7abc572c1bd239f2d2025-01-22T05:43:29ZengElsevierEClinicalMedicine2589-53702025-01-0179103002Noninvasive respiratory support following extubation in critically ill adults with obesity: a systematic review and network meta-analysisResearch in contextJoris Pensier0Arthur Naudet-Lasserre1Clément Monet2Mathieu Capdevila3Yassir Aarab4Inès Lakbar5Gérald Chanques6Nicolas Molinari7Audrey De Jong8Samir Jaber9Department of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR, 9214, Montpellier, FranceDepartment of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, FranceDepartment of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR, 9214, Montpellier, FranceDepartment of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR, 9214, Montpellier, FranceDepartment of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR, 9214, Montpellier, FranceDepartment of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR, 9214, Montpellier, FranceDepartment of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR, 9214, Montpellier, FranceMedical Information, IMAG, CNRS, Univ Montpellier, Centre Hospitalier Regional Universitaire de Montpellier, Montpellier, France; Institut Desbrest de Santé Publique (IDESP) INSERM - Université de Montpellier, Département d'informatique Médicale, CHRU Montpellier, FranceDepartment of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR, 9214, Montpellier, FranceDepartment of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, Montpellier, CEDEX 5, France; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR, 9214, Montpellier, France; Corresponding author. Intensive Care Unit, Anesthesia and Critical Care Department, Saint Eloi Teaching Hospital, University Montpellier 1, 80 avenue Augustin Fliche, 34295, Montpellier, CEDEX 5, France.Summary: Background: Patients with obesity are at high-risk of extubation failure. Discrepancies were found in the results of recent randomized controlled trials (RCTs) regarding the roles of noninvasive ventilation (NIV), high flow nasal cannula (HFNC) and conventional oxygen therapy (COT) to prevent extubation failure in critically ill patients with obesity. Methods: In this systematic review and network meta-analysis, we searched MEDLINE, Cochrane Center Register of Controlled Trials and Web of Science from 1 January 1998 to 1 July 2024 for RCTs evaluating noninvasive respiratory support therapies (NIV, HFNC, COT, NIV + HFNC) after extubation in critically ill adults with obesity. Primary outcome was reintubation at day 7. Secondary outcome was 28-day mortality. We generated pooled risk ratios (RR) and numbers needed to treat (NNT). We rated risk of bias using the Cochrane risk-of-bias 2.0 tool. The study was registered with PROSPERO (CRD 42022308995). Findings: In seven RCTs including 1933 patients, NIV + HFNC (RR 0.36 [95% confidence interval (CI) 0.16–0.82], NNT = 10 [95% CI 7–33]) and NIV (RR 0.45 [95% CI 0.23–0.88], NNT = 11 [95% CI 8–50]) but not HFNC (RR 0.79 [95% CI 0.40–1.59]) reduced reintubation at day 7, compared to COT. Compared to HFNC, NIV + HFNC (RR 0.46 [95% CI 0.23–0.90], NNT = 14 [95% CI 10–77]) but not NIV (RR 0.57 [95% CI 0.32–1.02]) reduced reintubation at day 7. Compared to HFNC, both NIV (RR 0.31 [95% CI 0.13–0.74], NNT = 15 [95% CI 12–40]) and NIV + HFNC (RR 0.30 [95% CI 0.10–0.89], NNT = 15 [95% CI 11–90]) reduced 28-day mortality. Interpretation: The results suggest that compared to COT and HFNC, NIV alone or with HFNC reduces reintubation in critically ill patients with obesity after extubation. Compared to HFNC, NIV alone or with HFNC reduces mortality. The number needed to treat with NIV or NIV + HFNC to avoid one death was 15. These findings support the application of NIV to mitigate extubation failure in critically ill adults with obesity. Funding: None.http://www.sciencedirect.com/science/article/pii/S2589537024005819Noninvasive ventilationBIPAPCPAPHigh-flow nasal cannula oxygenHFNOICU
spellingShingle Joris Pensier
Arthur Naudet-Lasserre
Clément Monet
Mathieu Capdevila
Yassir Aarab
Inès Lakbar
Gérald Chanques
Nicolas Molinari
Audrey De Jong
Samir Jaber
Noninvasive respiratory support following extubation in critically ill adults with obesity: a systematic review and network meta-analysisResearch in context
EClinicalMedicine
Noninvasive ventilation
BIPAP
CPAP
High-flow nasal cannula oxygen
HFNO
ICU
title Noninvasive respiratory support following extubation in critically ill adults with obesity: a systematic review and network meta-analysisResearch in context
title_full Noninvasive respiratory support following extubation in critically ill adults with obesity: a systematic review and network meta-analysisResearch in context
title_fullStr Noninvasive respiratory support following extubation in critically ill adults with obesity: a systematic review and network meta-analysisResearch in context
title_full_unstemmed Noninvasive respiratory support following extubation in critically ill adults with obesity: a systematic review and network meta-analysisResearch in context
title_short Noninvasive respiratory support following extubation in critically ill adults with obesity: a systematic review and network meta-analysisResearch in context
title_sort noninvasive respiratory support following extubation in critically ill adults with obesity a systematic review and network meta analysisresearch in context
topic Noninvasive ventilation
BIPAP
CPAP
High-flow nasal cannula oxygen
HFNO
ICU
url http://www.sciencedirect.com/science/article/pii/S2589537024005819
work_keys_str_mv AT jorispensier noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT arthurnaudetlasserre noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT clementmonet noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT mathieucapdevila noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT yassiraarab noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT ineslakbar noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT geraldchanques noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT nicolasmolinari noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT audreydejong noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext
AT samirjaber noninvasiverespiratorysupportfollowingextubationincriticallyilladultswithobesityasystematicreviewandnetworkmetaanalysisresearchincontext